© 2021 BioMarin. All rights reserved.
| Beta | 0.59 |
|---|---|
| Shares Outstanding | 182.7M |
| Average Volume (10 days) | 909.9K |
| Qtrly Dividend (Ann. Yield) | -- (--) |
| Earnings (TTM) | $4.08 |
|---|---|
| Sales (TTM) | $10.09 |
| Book Value (MRQ) | $22.78 |
| Cash Flow (TTM) | $1.12 |
| Cash (MRQ) | $5.98 |
| Current Mean Recommendation | Buy |
|---|
| Strong Buy | 10 | |
|---|---|---|
| Buy | 0 | |
| Hold | 6 | |
| Underperform | 0 | |
| Sell | 0 |
Brian Mueller EVP, Chief Financial Officer | (6,709) Sell May 7, 2021 |
|---|---|
Jean-Jacques Bienaime Director, Chief Executive Officer | (15,556) Sell May 7, 2021 |
Jean-Jacques Bienaime Director, Chief Executive Officer | (6,115) Sell May 7, 2021 |
Jean-Jacques Bienaime Director, Chief Executive Officer | (3,329) Sell May 7, 2021 |
Jean-Jacques Bienaime Director, Chief Executive Officer | (10,175) Sell May 6, 2021 |